InvestLog
LXEO logo

LXEO

Lexeo Therapeutics, Inc. Common StockNASDAQHealthcare
$5.72+0.87%ClosedMarket Cap: $417.5M

As of 2026-04-06

Recent Analyst Ratings
DateFirmActionRatingPrevious
2026-01-13Chardan Capital—Buy—
2026-01-13HC Wainwright & Co.—Buy—
2025-12-11Chardan Capital—Buy—
2025-11-05Chardan Capital—Buy—
2025-10-21HC Wainwright & Co.—Buy—
2025-10-07Leerink Partners—Outperform—
2025-08-15Chardan Capital—Buy—
2025-08-15Leerink Partners—Outperform—
2025-08-15HC Wainwright & Co.—Buy—
2025-05-30JP Morgan—Overweight—
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$-1.52$0.008
Fri Dec 31$-1.35$13.8M6
Sun Dec 31$-0.66$90.0M5
Mon Dec 31$0.76$278.1M1